A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
NCT05613569 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2024-07-08
Summary
This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study
Conditions
- Lumbosacral Radiculopathy
Interventions
- DRUG
-
KLS-2031
KLS-2031 administered by transforaminal epidural injection
Sponsors & Collaborators
-
Kolon Life Science
lead INDUSTRY
Principal Investigators
-
Todd Bertoch, MD · JBR Clinical Research
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-26
- Primary Completion
- 2026-08-30
- Completion
- 2027-04-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
TPN-101 in Aicardi-Goutières Syndrome (AGS)
NCT05613868 ·Status: TERMINATED ·Phase: PHASE2
-
A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
NCT02618512 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long Term Follow-Up for RGX-111
NCT06103487 ·Status: ENROLLING_BY_INVITATION
-
A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B
NCT02065011 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Long Term Follow-up on Menkes Disease Patients
NCT04337684 ·Status: ACTIVE_NOT_RECRUITING
-
Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy
NCT05506254 ·Status: ACTIVE_NOT_RECRUITING
-
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
NCT05066217 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Sebelipase Alfa in Participants With Lysosomal Acid Lipase Deficiency
NCT02112994 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
NCT01422187 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
NCT05422482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007
NCT06075537 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
NCT04991311 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study Evaluating The Safety And Tolerability of AMX0035
NCT05619783 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101
NCT04655911 ·Status: TERMINATED
-
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
NCT03533673 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
NCT05967351 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
NCT04874909 ·Status: COMPLETED ·Phase: NA
-
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
NCT02012114 ·Status: COMPLETED ·Phase: NA
-
Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
NCT04062981 ·Status: COMPLETED ·Phase: PHASE1
-
Study of SOM0226 in Familial Amyloid Polyneuropathy
NCT02191826 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
NCT07290257 ·Status: RECRUITING ·Phase: PHASE4
-
Follow-up Data of Patients Treated With XIGRIS® in France
NCT00803231 ·Status: COMPLETED
-
Long Term Follow-Up for Safety of AVR-RD-02
NCT06488261 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
NCT00735553 ·Status: TERMINATED ·Phase: PHASE3
-
Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I
NCT03071341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2